The adhesion molecule L1 is one of the few adhesion molecules known to be beneficial for repair processes in the adult central nervous system of vertebrates by promoting axonal growth and neuronal survival. In the peripheral nervous system, L1 is up-regulated by myelination-competent Schwann cells and regenerating axons after nerve damage but its functional role has remained unknown. Here we tested the hypothesis that L1 is, as in the central nervous system, beneficial for nerve regeneration in the peripheral nervous system by performing combined functional and histological analyses of adult L1-deficient mice (L1y/À) and wild-type (L1y/+) littermates. Contrary to our hypothesis, quantitative video-based motion analysis revealed better locomotor recovery in L1y/À than in L1y/+ mice at 4-12 weeks after transection and surgical repair of the femoral nerve. Motoneuron regeneration in L1y/À mice was also enhanced as indicated by attenuated post-traumatic loss of motoneurons, enhanced precision of motor reinnervation, larger cell bodies of regenerated motoneurons and diminished loss of inhibitory synaptic input to motoneurons. In search of mechanisms underlying the observed effects, we analysed peripheral nerves at short time-periods (3-14 days) after transection and found that Schwann cell proliferation is strongly augmented in L1y/À versus L1y/+ mice. L1-deficient Schwann cells showed increased proliferation than wild-type Schwann cells, both in vivo and in vitro. These findings suggest a novel role for L1 in nerve regeneration. We propose that L1 negatively regulates Schwann cell proliferation after nerve damage, which in turn restricts functional recovery by limiting the trophic support for regenerating motoneurons.
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Introduction
The neural cell adhesion molecule L1 is a glycoprotein of the immunoglobulin superfamily expressed in most, if not all, neurons in the central nervous system (CNS). During CNS development, L1 is targeted to the surface of developing axons and growth cones and mediates outgrowth, adhesion, fasciculation and guidance of axons as well as neuronal migration and survival (Hortsch, 2003; Maness and Schachner, 2007) . Perturbations of these processes by mutations in the L1 gene lead to brain malformations and dysfunctions in humans and mice (Maness and Schachner, 2007) . L1 is also implicated in CNS regeneration in adult vertebrates. After spinal cord injury in zebrafish, the expression of L1.1, a homolog of the mammalian L1, is increased in successfully regenerating descending axons but not in ascending projections that fail to regenerate (Becker et al., 2005) . Also, morpholino-mediated reduction of L1.1 expression leads to deficient regeneration (Becker et al., 2004) . Similar to poorly regenerating neurons in zebrafish, mammalian neurons fail to up-regulate L1 expression after CNS trauma (Styren et al., 1995; Mason et al., 2003) but L1 expression is up-regulated in CNS neurons when a peripheral nervous system (PNS) nerve bridge is introduced Woolhead et al., 1998) or L1 is overexpressed in Purkinje cells (Zhang et al., 2005) . When L1 expression in neurons and glia is induced by viral transduction , when L1 overexpressing embryonic stem cells are transplanted , or when the axonal growth-inhibiting environment is enriched in exogenous L1 (Roonprapunt et al., 2003) , recovery from spinal cord injury in rodents is enhanced. These findings clearly indicate that L1 is a molecule promoting CNS regeneration.
In the PNS, L1 is expressed in axons and Schwann cells during embryonic and early postnatal development and remains expressed by non-myelinating Schwann cells in the adult (Faissner et al., 1984; Nieke and Schachner, 1985; Martini and Schachner, 1986, 1988) . Constitutive ablation of L1 in mice does not lead to apparent PNS disorders. Neural crest cell migration is reduced in the developing gut of L1y/À mice but in the adult the entire gastrointestinal tract is colonized by enteric neurons (Anderson et al., 2006) . It has, thus, been suggested that L1 mutations contribute to Hirschsprung's disease, a human condition in which enteric neurons are absent from the distal bowel. L1y/À mice have mild impairments in locomotion and severely reduced pain sensitivity, but these deficits have been attributed to abnormal function of the CNS (Thelin et al., 2003; Jakeman et al., 2006) . Sprouting of calcitonin gene-related peptide positive sensory axons into the lesion site, which spontaneously occurs after spinal cord injury and is associated with development of pain, is reduced in L1y/À mice (Deumens et al., 2007) . In peripheral nerves of adult L1y/À mice, myelination is normal but the ensheathment of non-myelinated axons is disturbed (Dahme et al., 1997; Haney et al., 1999) . Peripheral nerve injury in adult rodents leads to up-regulation of L1 expression in myelination-competent Schwann cells distal to the injury site and enhanced expression in regenerating axons (Daniloff et al., 1986; Martini and Schachner, 1988; Martini, 1994) . However, the functional relevance of this up-regulation has not been elucidated.
We speculated, considering the regeneration-promoting properties of L1 in the CNS, that L1 is beneficial also for PNS regeneration. To test this hypothesis, we analysed peripheral nerve regeneration in L1y/À mice and wild-type (L1y/+) littermates using a wellestablished paradigm, femoral nerve transection and repair in adult mice combined with quantitative video-based analysis of motor recovery and cellular correlates of the functional outcome (Irintchev et al., 2005a; Eberhardt et al., 2006; Simova et al., 2006; Ahlborn et al., 2007) . Contrary to our expectation, however, we found superior outcome of nerve repair in L1y/À mice suggesting that ablation of L1 leading to enhanced proliferation of Schwann cells is beneficial for peripheral nerve regeneration.
Materials and Methods

Animals
We used 12-week-old L1-deficient (L1y/À) mice from a colony generated by insertion of a tetracycline-controlled transactivator into the second exon of the L1 gene (Rolf et al., 2001; Saghatelyan et al., 2004) . The L1y/À mice were males carrying the mutant allele of the X-chromosome-linked L1 gene. The wild-type (L1y/+) mice used as controls were male littermates of the L1y/À mice carrying the wild-type L1 allele. Unlike the L1y/À mice generated initially in our laboratory, which express residual amounts of L1 (Dahme et al., 1997) , these L1y/À mice were L1 null mice. Importantly, the L1y/À mice used here were maintained on a 129SvJ/NMRI genetic background which attenuates some abnormal features seen in L1y/À mice bred on a C57BL/6J background such as overt hydrocephalus, low body mass (60-80% of L1y/+ mice), poor breeding and high mortality of the L1y/À offspring within the first 2 months after birth. Before and after the experiments, the mice were kept on standard laboratory food and tap water ad libitum, with an artificial 12 h light/dark cycle. All treatments of the animals were conducted in accordance with the German and European Community laws on protection of experimental animals.
Experimental design
In Experiment 1 (see 'Nerve regeneration' below), we analysed functional recovery in L1y/À mice and L1y/+ littermates during a 12-week recovery period following femoral nerve injury (Fig. 1A) . Subsequently, these animals were subjected to retrograde labelling of regenerated motoneurons (Fig. 1B) and, following a survival period of 1 week, spinal cords and both injured and intact contralateral femoral nerves were sampled for histological analyses (Fig. 1A) . In addition to these 'injured' mice, i.e. subjected to femoral nerve transection and surgical repair, groups of control 'non-injured' L1y/À and L1y/+ mice were included in this experiment. These mice were subjected only to retrograde tracing (Fig. 1C) and used for morphological analysis of quadriceps motoneurons. In Experiment 2 ('Cell proliferation during Wallerian degeneration', Fig. 1D ), the femoral nerve of L1y/À and L1y/+ mice was transected and 3, 5, 7 and 14 days later the distal nerve segments were harvested for analyses of cell proliferation. Finally, in Experiment 3 an in vitro analysis was performed to investigate the proliferation of Schwann cells derived from 7-day-old L1y/À and L1y/+ mice.
Nerve regeneration
Transection and surgical repair of the femoral nerve Surgery was performed as described previously . The mice were anesthetized by intraperitoneal injections of 0.4 mg/kg fentanyl (Fentanyl-Janssen, Janssen, Neuss, Germany), 10 mg/kg droperidol (Dehydrobenzperidol, Janssen) and 5 mg/kg diazepam (Valium 10 Roche, Hoffman -La Roche, Grenzach-Wyhlen, Germany). The right femoral nerve was exposed and transected approximately 3 mm proximal to the bifurcation of the saphenous and quadriceps branches (Fig. 1B) . The cut ends of the nerve were inserted into a polyethylene tube (3 mm length, 0.58 mm inner diameter, Becton Dickinson, Heidelberg, Germany) and fixed with a single epineural 11-0 nylon stitch (Ethicon, Norderstedt, Germany) so that a 2 mm gap was present between the proximal and distal nerve stumps. Figure 1 Schematic representation of the experimental design. In Experiment 1, L1y/À and L1y/+ mice were subjected to unilateral transection and repair of the femoral nerve (at 0 weeks in A) proximal to the bifurcation of the sensory saphenous branch and the mixed quadriceps branch ('Nerve transection' in B). Recovery of function was followed by repeated video recordings over a 12-week period (A, arrowheads). At 12 weeks after injury, retrograde labelling of regenerated motoneurons was performed by transecting the two nerve branches distal to the bifurcation and application of two different fluorescence dyes, fluoro-ruby and Fast Blue to the saphenous and the quadriceps branch, respectively (B, 'Retrograde labelling'). One week later, femoral nerves and spinal cords were sampled for morphological analyses (A, elbow arrow). Additional control mice were subjected to retrograde labelling only (C) and served as controls in the morphological analyses. The circles on the left hand side in C represent motoneurons with axons targeting the quadriceps branch only and thus retrogradely labelled by Fast Blue but not with fluoro-ruby. After nerve regeneration, motor axons regenerate correctly to the quadriceps branch or aberrantly to the saphenous branch, or both nerve branches. Application of the two tracers allows the detection of both aberrantly and correctly projecting motoneurons (circles on the left hand side in B). The arrow at 'Analysis of axons' points to the approximate level at which axons were analysed in intact and regenerated nerves. In Experiment 2, mice of both genotypes were subjected to femoral nerve transection (0 day, D) and femoral nerves were sampled for analysis of Schwann cell proliferation at 3, 5, 7 and 14 days after injury (elbow arrows). Quantitative assessment of Schwann cell proliferation was performed at the level indicated in C. For further details see text.
The tube was filled with phosphate buffered saline (PBS, pH 7.4) and the skin was closed with 6-0 sutures (Ethicon). To prevent hypothermia, the mice were then kept in a warm room (35 C) until full recovery from anaesthesia.
Analysis of motor function
Functional analysis was performed over a time-period of 12 weeks (Fig. 1A ) using a quantitative video-based approach developed in our laboratory (single-frame motion analysis, Irintchev et al., 2005a) . To evaluate locomotor function, mice were accustomed, in 3-4 trials, to beam-walking prior to operation. In this test, the animal walks voluntarily from one end of a horizontal beam (length 1000 mm, width 40 mm) towards its home cage located at the other end of the beam. For all mice, a rear view of one walking trial was captured once prior to the operation and at different time-points after surgery ( Fig. 1A) with a high-speed camera (A602fc, Basler, Ahrensburg, Germany) at 100 frames per sec and stored on a personal computer in Audio Video Interleaved (AVI) format. The video sequences were examined using SIMI-Motion 7.0 software (SIMI Reality Motion Systems, Unterschleissheim, Germany). Selected frames in which the animals were seen in defined phases of the step cycle were used for measurements of two parameters: the heels-tail angle (HTA, Fig. 2A and C) and the foot-base angle (FBA, Fig. 2B and D) as described previously (Irintchev et al., 2005a) . Both parameters are directly related to the ability of the quadriceps muscle to keep the knee joint extended during contralateral swing phases. As a relative measure of functional recovery at different time-points after nerve injury, we calculated the stance recovery index (RI), which is a mean of the RI for the heels-tail angle and the foot-base angle. The index for each angle is calculated in percent as:
where X pre , X den and X reinn are values prior to operation, during the state of denervation (7 days after injury), and at any given time-point during reinnervation, respectively. A third parameter, the limb protraction length ratio (PLR), was evaluated from video-recordings of voluntary pursuit movements of the mice (Irintchev et al., 2005a) . The mouse, when held by its tail and allowed to grasp a pencil with its forepaws, tries to catch the object with its hindpaws and extends both hindlimbs simultaneously. In non-injured animals, the relative length of the two extremities, as estimated by lines connecting the most distal mid-point of the extremity with the anus, is approximately equal and the PLR (ratio of the right to left limb length) is close to 1.0. After denervation, the limb cannot be extended maximally and the PLR becomes significantly 41.0.
Retrograde labelling of motoneurons
At 12 weeks after nerve transection the animals were anaesthetized with fentanyl, droperidol and diazepam for retrograde labelling of regenerated motoneurons (Fig. 1A , Simova et al., 2006) . After exposure of the right femoral nerve, a piece of Parafilm (Pechiney Plastic Packaging, Chicago, IL, USA) was inserted underneath the nerve and the two nerve branches were transected approximately 5 mm distal to the bifurcation (Fig. 1B) . Fluorescence retro- grade tracers were applied to the cut nerve ends in powder form: fluoro-ruby (tetramethylrhodamine dextran, Molecular Probes, Leiden, The Netherlands) to the saphenous (cutaneous) branch (exclusively sensory branch), Fast Blue (EMS-Chemie, Großumstadt, Germany) to the quadriceps (muscle) branch (mixed nerve containing sensory and motor axons). Thirty minutes after dye application, the nerve stumps were rinsed with PBS and the wound was closed. This labelling procedure allows visualization of all femoralis motoneurons that have successfully regenerated their axons beyond the lesion site. In addition, it is possible to differentiate between motoneurons with axons correctly projecting into the quadriceps branch (blue circle in Fig. 1B ) and aberrantly projecting motoneurons sending axons to the saphenous branch only or to both the saphenous and the quadriceps branch (red and purple circle in Fig. 1B, respectively ). The same labelling procedure applied to 'non-injured' L1y/À and L1y/+ mice, i.e. mice which had not been subjected to nerve transection and repair ( Fig. 1C) , allows to estimate the normal number of quadriceps motoneurons all of which project to the quadriceps branch only (blue circles in Fig. 1C ).
Preparation of tissue for morphological analyses
One week after retrograde labelling ( Fig. 1A ) the mice were anesthetized by intraperitoneal injection of 16% sodium pentobarbital solution (Narcoren Õ , Merial, Hallbergmoos, Germany, 5 ml/g body weight) and were transcardially perfused with 4% formaldehyde in 0.1 M sodium cacodylate buffer, pH 7.3. The lumbar spinal cord was removed, post-fixed overnight at 4 C and then immersed in 15%
sucrose solution in 0.1 M cacodylate buffer, pH 7.3, for 1 day at 4 C. Afterwards the tissue was frozen for 2 min in 2-methyl-butane (isopentane, Carl Roth, Karlsruhe, Germany) pre-cooled to À30 C.
For sectioning, the spinal cord segment was attached to a cryostat specimen holder using TissueTek Õ (Sakura Finetek Europe, Zoeterwoude, The Netherlands). Serial transverse sections of 25 mm thickness were cut on a cryostat (Leica CM3050, Leica Instruments, Nußloch, Germany) and picked up on SuperFrost Õ Plus glass slides (Roth, Karlsruhe, Germany). The sections were air-dried for at least 1 h at room temperature (RT) and mounted in anti-quenching medium (Fluoromount G, Southern Biotechnology Associates, Biozol, Eching, Germany). These sections were used for counting retrogradely labelled motoneurons. Both injured and intact contralateral femoral nerves were dissected from perfusion fixed animals. The tissue samples were post-fixed in 1% osmium tetroxide (Polysciences Europe, Eppelheim, Germany) in 0.1 M sodium cacodylate buffer, pH 7.3, for 1 h at RT, dehydrated and embedded in resin according to standard protocols. One-mm thick cross-sections from the motor and sensory nerve branches were cut at a distance of $3 mm distal to the bifurcation (Fig. 1B) and stained with 1% toluidine blue/1% borax in distilled water for analysis of axon numbers, diameters, degree of myelination (g-ratios) in regenerated and intact nerve branches.
Counting of retrogradely labelled motoneurons
Serial transverse sections of spinal cord were examined under a fluorescence microscope (Axiophot 2, Zeiss, Oberkochen, Germany) with appropriate filter sets. Each section was examined using a 40Â objective by focusing through the section thickness starting from the top surface. All profiles, except those visible at the top surfaces of sections, were counted . The application of this simple stereological principle prevented double counting of labelled cells and allowed precise evaluation of cell numbers.
Immunofluorescence staining of perisomatic axon terminals
Immunofluorescence staining was performed as described (Irintchev et al., 2005b) using commercial antibodies at optimal dilutions (Table 1) . Sections of spinal cord containing retrogradely labelled motoneurons were freed from coverslips and mounting medium by soaking in PBS. Antigen retrieval was performed by immersion into 0.01 M sodium citrate solution, pH 9.0, heated to 70 C in a water bath for 30 min. Blocking of non-specific binding sites was then Cholinergic synaptic terminals Goat AB144P 1:100 Chemicon performed using PBS containing 0.2% Triton X-100 (Sigma), 0.02% sodium azide (Merck, Darmstadt, Germany) and 5% normal goat or normal donkey serum for 1h at RT. Incubation with primary antibodies against VGAT or ChAT (Table 1) , diluted in PBS containing 0.5% lambda-carrageenan (Sigma) and 0.02% sodium azide, was carried out at 4 C for 3 days. For a given antigen, all sections were stained in the same solution kept in screw-capped staining plastic jars (capacity 35 ml, 10 slides, Roth). After washing in PBS, appropriate Cy3-conjugated secondary antibodies (Jackson ImmunoResearch Europe, Suffolk, UK) diluted 1:200 in PBS-carrageenan solution were applied for 2 h at RT. After a subsequent washing in PBS, cell nuclei were stained for 10 min at RT with bis-benzimide solution (Hoechst 33258 dye, 5 mg/ml in PBS, Sigma) and the sections were mounted in anti-quenching medium. Specificity of staining was controlled by omitting the primary antibody or replacing it by an equivalent amount of non-immune IgG or serum derived from the same species as the specific antibody. These controls were negative.
Analyses of motoneuron size and perisomatic synaptic terminals
Sections containing retrogradely labelled motoneurons and additionally stained for ChAT and VGAT were used to estimate soma areas and motoneuron perisomatic coverage (Apostolova et al., 2006; Simova et al., 2006) . Linear density (number per unit length) of perisomatic terminals was estimated for motoneurons that correctly projected to the motor nerve branch of the femoral nerve (identified by Fast Blue back-labelling). Stacks of images of 1 mm thickness were obtained on a confocal microscope (Leica DM IRB, Leica, Wetzlar, Germany) using a 63Â oil immersion objective and digital resolution of 1024 Â 1024 pixels. One image per cell at the level of the largest cell body crosssectional area was used to measure soma area, perimeter and number of perisomatic puncta. These measurements were performed using the Image Tool 2.0 software program (University of Texas, San Antonia, TX, USA, http://ddsdx.uthscsa.edu/dig/).
Analyses of axons in the regenerated nerve branches
Total numbers of myelinated axons per nerve cross-section were estimated on an Axioskop microscope (Zeiss) equipped with a motorized stage and Neurolucida software-controlled computer system (MicroBrightField Europe, Magdeburg, Germany) using a 100 Â oil objective . Axonal and nerve fibre diameters were measured in a random sample from each section. For sampling, a grid with line spacing of 60 mm was projected into the microscope visual field using the Neurolucida software. Selection of the reference point (0 coordinates) of the grid was random. For all myelinated axons crossed by or attaching the vertical grid lines through the sections, mean orthogonal diameters of the axon (inside the myelin sheath) and of the nerve fibre (including the myelin sheath) were measured (Fig. 6A) . The mean orthogonal diameter is calculated as a mean of the line connecting the two most distal points of the profile (longest axis) and the line passing through the middle of the longest axis at right angle (Irintchev et al., 1990) . The degree of axonal myelination was estimated by the ratio axon to fibre diameter (g-ratio).
Analysis of cell proliferation during Wallerian degeneration
Femoral nerve surgery was performed as described above (Fig. 1B) avoiding the use of polyethylene tubes. The mice (n = 2-3 per genotype and time-point) were perfused 3, 5, 7 or 14 days after injury (Fig. 1D ) and the femoral nerve segments of $15 mm length, including the proximal and distal stumps, were post-fixed and cryoprotected by sucrose infiltration as described above. For indirect immunofluorescence, the tissue samples were immersed in TissueTek Õ medium and frozen in liquid nitrogen. Longitudinal (5 mm thick) and cross (10 mm thick) cryostat sections were used in single and double-labelling immunofluorescence experiments using antibodies listed in Table 1 . Indirect immunofluorescence was performed as described above for perisomatic terminals using the primary antibodies alone for single labelling or mixed at optimal dilutions for double labelling. Appropriate Cy3-and Cy2-conjugated antibodies preabsorbed with normal sera from diverse species to prevent crossreactions (Multiple Labeling antibodies, Jackson ImmunoResearch) were used in double labelling experiments. Specificity of staining was controlled by omitting the primary antibody or replacing it by an equivalent amount of non-immune IgG or serum. These controls were negative. Proliferating cells were quantified using nerves sampled 5 days after femoral nerve transection (Fig. 1D) , a time-point of maximal cell proliferation as indicated by Ki67 staining (Fig. 8D- 
Analysis of Schwann cell proliferation in vitro
Sciatic and femoral nerves were dissected from 7-day-old L1y/+ and L1y/À mice, freed of connective tissue and transferred into Petri dishes with ice-cold Ham's F-12 medium (PAA, Cö lbe, Germany). The nerves were treated with 0.25% trypsin (Sigma, Deisenhofen, Germany) and 0.03% collagenase (Sigma) in Dulbecco's modified Eagle medium (DMEM, PAA) for 30 min at 37 C. Enzymatic digestion was stopped by rinsing 2 Â with F-12 medium. The tissue samples were then transferred into complete (DMEM/Ham's F-12) medium containing 0.01% DNase I (Sigma). The complete medium consisted of equal parts DMEM and F-12 media and was supplemented with 60 ng/ml progesterone, 16 mg/ml putrescine, 5 mg/ml insulin, 400 ng/ml L-thyroxine, 160 ng/ml sodium selenite, 10.1 ng/ml triiodo-thyronine, 38 ng/ml dexamethasone (all from Sigma), 7.9 mg/ml glucose (VWR, Darmstadt, Germany), 0.01% bovine serum albumin, 100 IU/ml penicillin/streptomycin, 2 mM L-glutamine, 100 mM sodium pyruvate (all from PAA) and 20% horse serum (Invitrogen, Karlsruhe, Germany). Mechanical dissociation was performed by gentle trituration with a fire-polished Pasteur pipette. After adding of DMEM, the cell suspension was centrifuged at 500g for 10 min at 4 C in a centrifuge tube on top of a 4% BSA cushion. The supernatant was discarded and the cells were resuspended in 1 ml fresh pre-warmed (37 C) complete medium, counted and plated at a density of 2 Â 10 6 cells/ml on 0.01% poly-L-lysine-coated coverslips. After 4 h, 20 mM 5-bromo-2 0 -deoxyuridine (BrdU, Sigma) was applied to the cultures and the cells were grown for additional 48 h at 37 C in a CO 2 -enriched (5%) humidified atmosphere. Finally, the culture medium was removed and, after rinsing with PBS, the cells were fixed with 4% formaldehyde in PBS for 30 min at RT, rinsed 3Â with PBS and incubated with 2N HCl for 30 min at 37 C to denature DNA. After rinsing 2 Â with PBS, non-specific binding was blocked by incubation for 30 min with 5% normal goat serum (see below) in PBS at RT. The fixed cells were incubated with a mouse monoclonal antiBrdU antibody (see below) overnight at 4 C, washed 3 Â 5 min with PBS, incubated with a Cy3-conjugated goat anti-mouse secondary antibody (see below) for 1 h at RT, washed once with PBS and mounted in anti-quenching medium. Analysis of Schwann cell proliferation was performed using confocal images of randomly selected fields obtained on a confocal microscope (Olympus FV10-ASW, Hamburg, Germany). The percentage of proliferating Schwann cells (ratio of BrdU + to all Schwann cells) was estimated in 20 fields, each containing 100-200 cells, per cell culture preparation. At least three cultures were analysed per genotype. Schwann cells were identified by phase contrast microscopy as elongated bi-or tripolar cells with an oval soma ( Fig. 11A-C) . Fibroblasts appeared as flattened, polymorphic cells with large, round nuclei ( Fig. 11A-C) .
Results
Gait abnormalities in non-injured L1y/À mice
Frame-by-frame analyses of video sequences recorded prior to nerve transection (Fig. 1A) revealed differences between L1y/À and L1y/+ littermates. First, during the mid-stance phase, at maximum altitude of the contralateral swing, almost the entire planar paw surface of L1y/À mice contacted the ground ( Fig. 2A) . In contrast, only the digits of L1y/+ mice were on the ground during this gait phase (Fig. 2C) . Second, the external rotation of the paw at take-off position was more pronounced in L1y/À than in L1y/+ mice ( Fig. 2B and D) . Consequently, L1y/À mice had different heels-tail angles and the foot-base angles ( Fig. 2A-F) , two measures used to estimate quadriceps muscle function after femoral nerve lesion (Irintchev et al., 2005a) . However, the observed deviations of the angle values from normal in uninjured L1y/À mice were opposite to the changes induced by femoral nerve injury ( Fig. 2E and F) and, thus, could not be attributed to quadriceps muscle weakness.
Enhanced functional recovery after nerve repair in L1y/À mice
Despite genotype-related differences in gait prior to operation, damage of the femoral nerve-induced changes in the heels-tail and the foot-base angles similar in magnitude in L1y/À and L1y/+ mice (compare values at 0 and 1 week after injury in Fig. 2E and F) . These alterations were caused by impaired extensor function of the quadriceps muscle leading to abnormally high heel position and external rotation of the ankle at gait cycle positions similar to those seen in Fig. 2A and C and Fig. 2B and D, respectively. Importantly, at 1 week after injury, no significant differences were found between L1y/À and L1y/+ mice ( Fig. 2E and F, ANOVA with Tukey's post hoc test). After the first week, the angles in L1y/+ mice gradually returned to normal but recovery was deficient, as compared to normal values, even after 12 weeks ( Fig. 2E and F, P50.05, ANOVA with Tukey's post hoc test). Locomotor improvement in L1y/À mice was superior compared with L1y/+ mice at 4-12 weeks after injury ( Fig. 2E and F) . Also, as estimated by the stance RI, a measure of the individual degree of recovery calculated for both angles, the final outcome of femoral nerve repair was significantly better in L1y/À than in L1y/+ mice (87 AE 14% versus 60 AE 8.5% recovery, P50.05, t-test, Fig. 2H ). In addition to ground locomotion, we also evaluated the ability of the animals to extend the knee joint during movements without body weight support using the 'pencil' test (Irintchev et al., 2005a) . This ability, estimated by the limb PLR (length of the non-injured hindlimb/length of injured limb during maximum extension), was similar in L1y/À and L1y/+ mice before operation (Fig. 2G) . Also, the degree of disability at 1 week after operation and the recovery thereafter were similar in the two genotypes (Fig. 2G ). In conclusion, the combined results show that L1 ablation leads to a superior functional outcome.
Reduced numbers of quadriceps motoneurons in non-injured L1y/À mice
The number of retrogradely labelled quadriceps motoneurons was significantly lower, by 29%, in non-injured L1y/À mice compared non-injured L1y/+ littermates (Fig. 3) . In both phenotypes, only Fast Blue labelled motoneurons were observed indicating that all motoneurons project to the quadriceps nerve branch only (Fig. 1C) . No small (microglial) cells loaded with Fast Blue, as a result of phagocytosis of retrogradely labelled motoneurons , were detected in spinal cord sections from L1y/À and L1y/+ mice indicating that motoneuron death in L1y/À mice during the 1 week labelling period was not the reason for the reduced number of labelled motoneurons. The finding of reduced number of motoneurons in L1y/À mice, in conjunction with a lower than normal number of myelinated axons in non-injured nerves (see following section) and normal body mass in L1y/À mice (35 AE 1.7 g versus 36 AE 2.8 g in L1y/À and L1y/+ mice, respectively, P 40.05, t-test), indicates that L1 ablation leads to a deficient development and/or maintenance in the adult of the quadriceps motoneuron pool.
Better motoneuron survival and regeneration in injured L1y/À mice At 12 weeks after nerve repair, the total number of motoneurons retrogradely labelled through the motor (quadriceps) or the sensory (saphenous) branch only, or through both branches of the femoral nerve, was significantly reduced (À32%) in injured compared with non-injured L1y/+ mice (Fig. 3) . In contrast to L1y/+ mice, the total number of regenerated motoneurons in injured L1y/À mice was similar to the number in non-injured L1y/ À animals (Fig. 3) . In both genotypes, small fractions of all labelled motoneurons projected aberrantly to the sensory branch only, or to both the motor and the sensory branches (Fig. 3) . Also in both genotypes, the majority of regenerated motoneurons had axons which had re-grown only into the appropriate motor nerve branch-a feature of preferential motor reinnervation (PMR, Fig. 3) (Brushart, 1988) . However, the degree of PMR, estimated as index of PMR (motoneurons projecting to the motor branch/ motoneurons projecting to the sensory branch), was significantly higher in L1y/À mice compared with L1y/+ mice (4.4 AE 1.1 versus 2.0 AE 0.52, respectively, P50.05, t-test). In conclusion, the results show better motoneuron regeneration in L1y/À compared with L1y/+ mice: motoneuron loss and/or failure of regeneration are reduced and precision of motor reinnervation is improved.
L1 deficiency does not influence axonal regeneration
Next we analysed non-injured and regenerated nerves morphologically to assess axonal numbers, axonal diameters and degree of myelination. In both the motor and sensory branches of the femoral nerve, we found a significant reduction in the total number of myelinated axons in non-injured L1y/À mice (by 17 and 26%, respectively) compared with L1y/+ littermates ( Fig. 4A  and B) . At 12 weeks after injury, the numbers of regenerated axons in the motor and sensory branches of the femoral nerve were reduced compared with non-injured nerves in both L1y/À (by 27 and 34%, respectively) and L1y/+ mice (by 26 and 35%, respectively, Fig. 4A and B) . The axonal numbers in the regenerated nerve branches were not significantly different between L1y/À and L1y/+ mice. Also, no differences between the genotypes were found for axonal diameters and relative degree of myelination (g-ratio) in non-injured or regenerated nerves (Figs 5 and 6) with one exception. The frequency distribution of axonal diameters in the non-injured motor branch of L1y/À mice was partially shifted towards larger values (P50.05, KolmogorovSmirnov test) indicating that a fraction of the axons in L1y/À mice had larger than normal diameters (Fig. 5) . With regard to nerve repair, we can conclude that L1 ablation in both axons and Schwann cells does not influence axonal regrowth and remyelination as estimated at 12 weeks after injury.
Larger soma size and attenuated loss of inhibitory synaptic input to regenerated L1y/À motoneurons
The soma size of motoneurons in L1y/À and L1y/+ mice with or without preceding injury of the femoral nerve ('Injured' and 'Non-injured' groups in Fig. 7D , respectively) was evaluated only for motoneurons projecting to the quadriceps muscle as detected by retrograde labelling (blue cells in Figs 1B and 7A ). Both non-injured and injured L1y/À mice had larger motoneurons compared with the respective groups of L1y/+ mice (by 20 and 16%, respectively, Fig. 7D ).
Analysis of inhibitory (GABAergic and glycinergic, VGAT + ) terminals and modulatory cholinergic (ChAT + ) terminals around motoneuron perikarya revealed differences between the genotypes in mice without injury ('Non-injured' groups in Fig. 7E and F). Density (number per mm) of VGAT + terminals was lower and that of ChAT + puncta higher in L1y/À compared with L1y/+ mice (20 and 22%, respectively). After nerve injury ('Injured' groups in Fig. 7E and F) , densities of ChAT + terminals in both genotypes
were not changed compared with the respective non-injured Figure 3 Analysis of motoneuron regeneration. Mean numbers of motoneurons (AESEM) labelled through the motor or sensory branch only (grey and dark grey bars, 'Motor' and 'Sensory', respectively), through both branches (light grey bars, 'Both'), and the sum of neurons in the first three categories (black bars, 'Total') 12 weeks after femoral nerve repair in L1y/À and L1y/+ mice (right-hand half of the graph, 'Injured', 6/6 animals of L1y/À and L1y/+ mice, respectively) and non-injured mice ('Non-injured' on the left-hand side, 10/13 animals of L1y/À and L1y/+ mice, respectively). In non-injured mice retrograde tracing but no previous nerve injury was performed. Asterisks and hash indicate differences between non-injured and injured groups of the same genotype and between L1y/+ and L1y/À animals under the same experimental conditions, respectively (P50.05, one-way ANOVA with Tukey's post hoc test).
Figure 4
Analysis of myelinated axons in non-injured and regenerated motor (A) and sensory (B) nerve branches at 12 weeks after injury in L1y/À and L1y/+ mice ('Injured', n = 11 and 10, respectively) and in non-injured contralateral nerves ('Non-injured', n = 13 and 6, respectively). Asterisks and hash indicate differences between non-injured and injured groups of the same genotype and between L1y/+ and L1y/À animals under the same experimental conditions, respectively (P50.05, one-way ANOVA with Tukey's post hoc test).
group as also were VGAT + boutons in L1y/À mice. In contrast to L1y/À mice, VGAT + terminals were reduced in injured compared with non-injured L1y/+ animals (À22%). We can conclude that synaptic coverage related to nerve injury differs in L1y/+ and L1y/ À mice. Particularly interesting from a functional point of view is the finding that nerve repair-related loss of inhibitory terminals in L1/+ mice was not found in L1y/À mice.
Enhanced Schwann cell proliferation in L1y/À mice after nerve damage
We analysed sections from femoral nerves 3, 5, 7 and 14 days after injury in L1y/+ and L1y/À mice (Fig. 1D ) using the L1 antibody 555 and antibodies recognizing Schwann cell and axonal antigens, S-100 and ß-tubulin, respectively (data not shown).
While L1 could not be detected in L1y/À samples, L1 was up-regulated after nerve transection. The number of S-100-positive cells was higher, at any time-point studied (2-3 animals studied per time-point and genotype), in L1y/À versus L1y/+ mice ( Fig. 8A-C) . A similar difference between the genotypes was found for another Schwann cell marker, GFAP (not shown). These observations suggested that L1 deficiency influences Schwann cell proliferation after nerve injury. We used an antibody against the Ki67 antigen to assess cell proliferation. At any timepoint after injury studied, the number of Ki67-positive cells in longitudinal sections of L1y/À mice exceeded by at least two-fold the numbers in L1y/+ mice ( Fig. 8D-F  0 ) . To verify the possibility that most of these proliferating cells are Schwann cells, we performed co-localization experiments in sections of the femoral nerve 5 days after injury using antibodies against Ki67 and Schwann cell markers, S-100 and GFAP (Fig. 1D) . No co-localization of Ki67 + nuclei and S-100 + (Fig. 9A-A  0 ) or GFAP + (not shown) cell profiles was found. However, most Ki67 + nuclei in both genotypes appeared to co-localize with laminin, a basal Regenerated nerves were studied 12 weeks after injury. Number of axons and nerves studied per group are shown in the panels. A significant difference between the genotypes was detected only for the non-injured motor nerve branches (A, P50.05, Kolmogorov-Smirnov test). This difference indicates increased proportion of large-diameter axons in the motor branch of L1y/À mice. Abnormally thick axons (413 mm) were not present in L1y/À animals as illustrated by images of semithin sections from the motor nerve branches of an L1y/À and an L1y/+ mouse (E and F). Figure 6 Analysis of myelination in regenerated and non-injured nerves. Mean orthogonal diameters of the axon (A, black arrows) and of the nerve fibre (A, white arrows) were measured and the degree of myelination was estimated by the ratio axon to fibre diameter (A, g-ratio). Shown are normalized frequency distributions of g-ratios in non-injured (B and C) and regenerated (D and E) motor (B and D) and sensory (C and E) nerve branches of the femoral nerve in L1y/À and L1y/+ mice. Regenerated nerves were studied 12 weeks after injury. Number of axons and nerves studied per group are identical with those shown in Fig. 4 . No differences between the genotypes were detected for any pair of samples (P40.05, Kolmogorov-Smirnov test).
lamina component produced by Schwann cells (Fig. 9B-B  0 ) .
No co-localization of Ki67 + nuclei and the macrophage marker F4/80 was observed (Fig. 9C-C  0 ) . Finally, analysis of apoptotic cells using an antibody against activated caspase-3 did not reveal differences between the genotypes at any time-point studied (not shown).
Since the differentiation-associated proteins S-100 and GFAP did not co-localize with Ki67, Schwann cell proliferation was quantified using an antibody against the p75 NGF receptor which is expressed in proliferating Schwann cells. At 5 days after femoral nerve transection (Fig. 1D) , when cell proliferation was estimated to be maximal (Fig. 8D-F 0 ), the number of proliferating Schwann cells (both p75 + and Ki67 + , designated as type Ia in Fig. 10A ) was higher in L1y/À than in L1y/+ mice irrespective of whether this number was normalized to proliferating non-Schwann cells (Ki67 + , p75 À , type IIa, Fig. 10B )-by 26%, to all nuclei in a nerve crosssection (by 36%, Fig. 10C ) or nerve cross-sectional area (by 20%, Fig. 10D ). Thus, L1 deficiency leads to enhancement of Schwann cell proliferation after nerve injury.
Enhanced proliferation of Schwann cells from L1y/À mice in vitro
Immunofluorescence detection of BrdU and phase contrast analysis revealed BrdU labelling in nuclei of two types of cell in the cultures: elongated bi-or tripolar cells with an oval soma and small nuclei, considered to be Schwann cells (Brockes et al., 1979; Scarpini et al., 1986; Honkanen et al., 2007) , and fibroblast-like cells with flattened, polymorphic appearance and large round nuclei (Fig. 11A-C) . Quantitative analysis revealed that a higher proportion of the cells with Schwann cell morphology had incorporated BrdU in cultures derived from L1y/À mice compared with L1y/+ cultures (57 and 39%, respectively, Fig. 11D ), a finding supporting the observations made in vivo.
Discussion
The results of this study show that L1 deficiency in mice has a favourable impact on functional recovery after peripheral nerve damage. Improved functional outcome was paralleled by positive effects on regeneration including attenuated post-traumatic loss of motoneurons, enhanced precision of reinnervation of the femoral motor, and thus appropriate, nerve branch by motoneuron axons, larger cell bodies of regenerated motoneurons and diminished loss of inhibitory synaptic input to motoneurons. These phenomena are associated with enhanced proliferation, and thus higher numbers, of the growth-supportive denervated Schwann cells in injured nerves of L1y/À mice. Functional and structural deficits in uninjured L1y/À mice Analyses of non-injured L1y/À mice revealed deficits, as compared with L1y/+ littermates, in numbers of quadriceps motoneurons and numbers of myelinated axons in the motor and sensory branches of the femoral nerve. These differences could be caused by target factors such as, for example, reduced muscle mass despite normal body weight. Since L1 has been found to support neuronal survival in vitro (Hulley et al., 1998; Chen et al., 1999; Loers et al., 2005) , we favour the view that L1 deficiency in motoneurons leads to loss of motoneurons and sensory neurons which in turn results in lower numbers of axons in the peripheral nerves. Deficient motoneuron numbers may also contribute to the mild gait deficits observed in our L1y/À mice on 129/SvJ/NMRI background and previously in L1y/À mice on a C57BL/6J/129S7 genetic background (strain B6; 129S7-L1cam tm1Sor /J, Jackson Laboratory, Bar Harbor, ME, USA, Jakeman et al., 2006) . If numbers of muscle fibres are not reduced by ablation of L1, motoneuron deficit would lead to an increase in motor unit size (number of muscle fibres innervated by one motoneuron) in L1y/À mice. In association with abnormal sensory inputs, this could contribute to reduced precision of motor control. In line with the idea of increased motor unit size are the observations of larger somata of retrogradely labelled quadriceps motoneurons and increased axonal diameters in the motor branch of the femoral nerve of L1y/À mice. In contrast to other deficits, non-injured L1y/À mice had the same myelination as L1y/+ animals in both branches of the quadriceps nerve estimated by g-ratio.
Enhanced outcome of nerve injury in L1y/À mice Previous studies have shown that homophilic L1 interactions promote neurite outgrowth on cultured Schwann cells (Bixby et al., 1988; Kleitman et al., 1988; Seilheimer and Schachner, 1988) . Therefore, our initial expectation was to find at least delayed recovery, if not inferior final outcome in L1y/À mice. We surprisingly observed better locomotor recovery in L1y/À mice than in L1y/+ littermates. L1y/À mice showed subtle abnormalities in gait prior to operation. However, the degree of impairment after injury was similar in L1y/À and L1y/+ mice as indicated by the parallel and equal in extent changes occurring between 0 and 7 days in both genotypes ( Fig. 2E and F) . Therefore, L1y/À and L1y/+ mice suffer from the injury to the same extent. Better functional recovery in L1y/À mice became apparent first at 4 weeks after injury indicating lack of advantages during the early phase of regeneration. At 12 weeks after injury, motoneuron survival/axonal regrowth, as assessed by retrograde labelling, was also better in L1y/À mice. Compared with noninjured mice of the same genotype, number of regenerated retrogradely labelled motoneurons was reduced in L1y/+ but not in L1y/À mice. Also, PMR after nerve injury was more pronounced and somata of regenerated motoneurons were larger in L1y/À than in L1y/+ mice. Similar effects on motoneuron survival and regrowth and a similar time-course of functional improvement were found after femoral nerve injury and application of a peptide mimic of the HNK-1 (human natural killer cell) glycan in mice which is expressed in myelinated axons of the motor, but not sensory branches of the mouse femoral nerve. We interpret such findings as indications of trophic effects on motoneurons after axotomy, an interpretation in line with the observation of enhanced Schwann cell proliferation in L1y/À mice observed here. It is, however, also conceivable, that the enhanced functional improvement in L1y/À mice is additionally related to attenuated susceptibility to injury of motoneurons that have survived as the most resistant ones to developmental elimination.
L1 and synaptic connectivity of motoneurons
This study provides also, for the first time, data on perisomatic coverage of motoneurons by VGAT + (glycinergic and GABAergic) and ChAT + (cholinergic) axon terminals after nerve injury. Considering the results for L1y/+ mice, two observations appear important. First, the number of cholinergic boutons on motoneurons was similar before and after injury. This is in contrast to the dramatic reduction of this synaptic input to lumbar motoneurons after thoracic spinal cord injury in mice which correlates with reduced locomotor recovery (Apostolova et al., 2006; Jakovcevski et al., 2007) . These two observations suggest that injury-induced alterations in the modulatory cholinergic innervation of motoneurons (Miles et al., 2007) do not contribute to motor deficits after nerve regeneration. Second, regenerated motoneurons were deficiently innervated by inhibitory terminals at 12 weeks after injury compared with non-injured motoneurons in L1y/+ mice. This deficit is likely related to functional impairments after nerve regeneration since perisomatic inhibition is crucial for normal motoneuron function. Considering genotype specific effects, it is interesting that non-injured L1y/À motoneurons were surrounded by more cholinergic and less inhibitory boutons than L1y/+ motoneurons. At present it cannot be judged whether these differences in synaptic coverage represent compensations for or contribute to functional impairments in noninjured L1y/À mice. And finally, no loss of inhibitory terminals in regenerated L1y/À motoneurons compared with non-injured L1y/À motoneurons was found-in contrast to L1y/+ mice-a feature that might favour enhanced locomotor recovery. The combined observations indicate that L1 deficiency causes alterations, as compared with L1y/+ mice, in synaptic connectivity of motoneurons in the non-injured spinal cord and after peripheral nerve regeneration.
Enhanced Schwann cell proliferation as a mechanism underlying enhanced functional recovery in L1y/À mice After nerve injury, the Schwann cells in the distal nerve stump switch their mode from myelination of electrically active axons to growth support for regenerating axons (Mirsky and Jessen, 1999; Scherer and Salzer, 2001) . Denervated Schwann cells proliferate, align in chains, bands of Bü ngner, inside endoneurial tubes (basal laminae deposited by Schwann cells) and act as cellular and molecular guides for the regenerating axons. Moreover, the switch in Schwann cell phenotype after injury is associated with downregulation of myelin-associated genes, up-regulation of several growth-associated genes, and increased production of neurotrophic factors and extracellular matrix proteins supporting neuronal survival and axonal regrowth (Fu and Gordon, 1997; Scherer and Salzer, 2001; Moran and Graeber, 2004) . If this support is reduced by, for instance, longterm denervation during adulthood or persistence of Schwann cell immaturity in early postnatal animals, regeneration is compromised (Fenrich and Gordon, 2004; Moran and Graeber, 2004) . In light of Figure 9 Analysis of proliferating cells in vivo. Cross-sections from the quadriceps (motor) branch (on the left hand side in each pair of sections) and the saphenous (sensory) branch of the femoral nerve of L1y/À mouse (A-C) and an L1y/+ littermate (A 0 -C 0 ) cut from nerve segments distal from the site of injury at 5 days after injury (Fig. 1D) . Ki67 + nuclei co-localize with laminin (B and B 0 ) but not with S-100 (A and A 0 ) or with the macrophage marker F4/80 (C and C 0 ). Scale bar indicates 25 mm.
this knowledge, better regeneration and functional recovery in L1y/À mice can be explained by enhanced Schwann cell proliferation during the period of Wallerian degeneration. Higher number of Schwann cells may provide enhanced trophic support by neurotrophins, cytokines and other factors thus positively influencing, not only motoneurons, but also sensory neurons and improve their survival and promote the restoration of afferent connections.
A relationship between L1 expression and Schwann cell proliferation has not been reported or considered previously. The only exception is the finding that reduction of Schwann cell proliferation by serum deprivation in vitro augments L1 expression (Takeda et al., 2001) . One possible explanation for the effect of L1 ablation on cell proliferation in vivo is delayed differentiation, and thus prolonged proliferation, of Schwann cells after contact with regrowing axons as a result of L1 deficiency in both interacting cell types. Disruption of homophilic L1 interactions (Bixby et al., 1988; Kleitman et al., 1988; Seilheimer and Schachner, 1988 ) may underlie such an effect. While this hypothesis has to be tested, our experiments with primary Schwann cell cultures, which are devoid of nerve cells but contain L1-negative fibroblast-like cells, indicate that L1-mediated control of cell proliferation is exerted via Schwann cell-extracellular matrix interactions or cis-interactions between L1 and other molecules on the Schwann cell membrane. One possibility is that L1 suppresses cell proliferation by binding to integrins on the surface of Schwann cells. For example, interaction of L1 with a7b1-integrin, a receptor for laminin-2 on Schwann cells (Chernousov et al., 2007) , through RGD motifs in the sixth immunoglobulin domain of L1, can modulate integrin-mediated signalling and thus cell proliferation (Itoh et al., 2004 (Itoh et al., , 2005 Armstrong et al., 2007; Maness and Schachner, 2007) . Another possibility is that loss of the interaction of L1 with the fibroblast growth factor receptor 1 Figure 10 Analysis of Schwann cell proliferation in vivo. Cross-section from the quadriceps (motor) branch of the femoral nerve of an L1y/+ mouse (A) cut $3 mm distal from the site of injury at 5 days after injury (Fig. 1D) (FGFR1) in L1y/À Schwann cells promotes proliferation (Dong et al., 1997) . Upon fibronectin type III domain-mediated binding of L1 to FGFR1, the receptor is phosphorylated and this favours differentiation and axonal growth in neurons rather than proliferation (Loers et al., 2005; Kulahin et al., 2008) . The importance of FGF-2 signalling in the control of Schwann cell proliferation has previously been demonstrated using mice overexpressing FGF-2 (Jungnickel et al., 2006) . These transgenic mice show enhanced Schwann cell proliferation but, in contrast to our L1y/À mice, no superior functional outcome of peripheral nerve injury compared with wild-type mice was detected. These observations do not contradict our hypothesis that increased numbers of Schwann cells during Wallerian degeneration favour the final outcome of nerve injury since FGF-2 overexpression stimulates signalling not only via the regeneration-promoting FGFR1, but also via FGFR3, which has a negative impact on nerve regeneration (Jungnickel et al., 2004) .
L1 and myelination
Although L1 is involved in myelination in vitro (Seilheimer et al., 1989; Wood et al., 1990; Coman et al., 2005) , peripheral nerve myelination in L1y/À mice is normal (Dahme et al., 1997; Haney et al., 1999) . Here, we found similar degrees of myelination in L1y/À and L1y/+ mice for both non-injured and regenerated nerves. These findings are in agreement with the conclusion of Martini and Schachner (1986, 1988) based on analyses of L1 expression during nerve development and regeneration, that L1 is not essential for the maintenance of compact myelin. However, the expression pattern observed in these studies suggested that L1 is involved in initial axon-Schwann cell interactions and at the onset of myelination. Our findings, therefore, do not preclude a role of L1 in myelination. During normal development until adulthood and within a 12-week recovery period after nerve injury, compensatory mechanisms may overcome an L1-related delay in myelination.
In conclusion, the results of this study indicate that L1, in contrast to its role in the injured CNS, has a negative impact on peripheral nerve regeneration, implicating L1's suppression of Schwann cell proliferation and thus reduced trophic support that proliferating, denervated Schwann cells convey to neurons. Ensuing L1-related enhancement of differentiation may then be counteractive to regeneration after injury in the adult PNS. These findings warrant experiments designed to test the potential of a functional, but transient block of L1 expression by Schwann cells in the regenerating nerve, using, for example, neutralizing antibodies, to improve of the outcome of nerve injury. An alternative strategy would be to transiently stimulate Schwann cell proliferation, and thereby improve the functional outcome after injury, by applying Schwann cell mitogens during the period of Wallerian degeneration.
